GulamAbbasManjiMDPhD

PubMed

• Tumor-selective activity of RAS-GTP inhibition in pancreatic cancer.
  Urszula N Wasko, Jingjing Jiang, Tanner C Dalton, Alvaro Curiel-Garcia, A Cole Edwards, Yingyun Wang, Bianca Lee, Margo Orlen, Sha Tian, Clint A Stalnecker, Kristina D...> ;Nature. 2024 Apr 8
• A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.
  Jacob K Jamison, Michael S May, Alexander G Raufi, Lyndon Luk, Winston Wong, Prabhjot S Mundi, Gulam A Manji> ;The Oncologist. 2024 Apr 4
• Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma.
  Wasko, U., Jiang, J., Curiel-Garcia, A., Wang, Y., Lee, B., Orlen, M., Drizyte-Miller, K., Menard, M., Dilly, J., Sastra, S., Palermo, C., Dalton, T., Hasselluhn, M., ...> ;Biorxiv. 2023 Dec 4
• 2 citations
  Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
  Manji, G., Lee, S., Del Portillo, A., May, M., Ana, S., Alouani, E., Sender, N., Negri, T., Gautier, K., Ge, L., Fan, W., Xie, M., Sethi, A., Schrope, B., Tan, A., Par...> ;JAMA Oncology. 2023 Dec 1
• Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer.
  Meredith LaRose, Gulam A Manji, Susan E Bates> ;Seminars in Oncology. 2023 Nov 24
• 1 citations
  SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMRV600E-mutant mCRC.
  Elena Elez, Scott Kopetz, Josep Tabernero, Tanios Bekaii-Saab, Julien Taieb, Takayuki Yoshino, Gulam Manji, Kathrine Fernandez, Antonello Abbattista, Xiaosong Zhang, V...> ;Future Oncology. 2024 Apr 1
• Filippo Giancotti (1958-2023).
  Ronald DePinho, Joan Massagué, Gulam Manji, Anil K Rustgi, Benjamin Izar> ;Nature Cancer. 2023 Oct 1
• Reply to C. Springfeld et al.
  Gulam A Manji> ;Journal of Clinical Oncology. 2023 Sep 1
• 5 citations
  Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
  Ko, A., Kim, K., Siveke, J., Lopez, C., Lacy, J., O'Reilly, E., Macarulla, T., Manji, G., Lee, J., Ajani, J., Alsina Maqueda, M., Rha, S., Lau, J., Al-Sakaff, N., Alle...> ;The Oncologist. 2023 Jun 2
• Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer.
  Michael S May, Jacob K Jamison, Winston Wong, Alissa Michel, Alexander G Raufi, Alfred I Neugut, Gulam A Manji> ;Cancer Investigation. 2023 May 1
• 4 citations
  A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies.
  Prabhjot S Mundi, Filemon S Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R Rainey, Kristina Guillan, Armaan Siddiquee, Daoqi You, Ronald Realubit, ...> ;Cancer Discovery. 2023 Jun 2
• Adjuvant Gemcitabine and Nab-Paclitaxel Misses the Target in Pancreas Adenocarcinoma: Or Did an Effective Therapy Fall to the Definition of Recurrence?
  Manji, G.> ;Journal of Clinical Oncology. 2023 Apr 10
• 2 citations
  KRAS: Druggable at Last.
  Benjamin O Herzberg, Manji, G.> ;The Oncologist. 2023 Apr 6
• 1 citations
  Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer.
  H Carlo Maurer, Alvaro Curiel-Garcia, Sam Holmstrom, Pasquale Laise, Carmine F Palermo, Steven A Sastra, Anthony Andren, Zhang Li, Tessa LeLarge, Irina Sagalovskiy, Da...> ;Biorxiv. 2023 Mar 21
• 4 citations
  Pervasiveness of HLA allele-specific expression loss across tumor types.
  Ioan Filip, Anqi Wang, Oleksandr Kravets, Rose Orenbuch, Junfei Zhao, Tomin E Perea-Chamblee, Evangelina López de Maturana, Núria Malats, Kenneth P Olive, Raul Rabadan...> ;Genome Medicine. 2023 Feb 9
• 1 citations
  Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
  Celine Yeh, Mengxi Zhou, Keith Sigel, Gayle Jameson, Ruth White, Rachael Safyan, Yvonne Saenger, Elizabeth Hecht, John Chabot, Stephen Schreibman, Béata Juzyna, Marc Y...> ;The Oncologist. 2023 Feb 8
• 3 citations
  Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer.
  Alexander S Thomas, Wooil Kwon, David P Horowitz, Susan E Bates, Antonio T Fojo, Gulam A Manji, Stephen Schreibman, Beth A Schrope, John A Chabot, Michael D Kluger> ;Journal of Surgical Oncology. 2022 Dec 1
• 3 citations
  Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in borderline resectable/locally advanced pancreatic cancer patients.
  Myles A Ingram, Brianna N Lauren, Yoanna Pumpalova, Jiheum Park, Francesca Lim, Susan E Bates, Fay Kastrinos, Gulam A Manji, Chung Yin Kong, Chin Hur> ;Cancer Reports. 2022 Sep 1
• 22 citations
  A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath T...
  Brian A. Van Tine, Shing M. Lee, Alexander G. Raufi, Ilenia Pellicciotta, Angela C. Hirbe, Jaya Sarin Pradhan, Andrew X. Chen, Raul Rabadan, Gary K. Schwartz> ;Clinical Cancer Research. 2021 Oct 15
• 5 citations
  Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature.
  Michael May, Alexander G. Raufi, Sina Sadeghi, Karen Chen, Alina Iuga, Yu Sun, Firas S. Ahmed, Susan E. Bates> ;The Oncologist. 2021 Aug 1
• 29 citations
  Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment
  Anna M. Chiarella, Yun K. Ryu, Anil K. Rustgi> ;Trends in Cancer. 2021 Aug 1
• 2 citations
  A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy.
  Winston Wong, Claire Brieva, Michael May, Karen Gambina, Susan Whittier, Eldad A. Hod, Ilenia Pellicciotta, Samuel Pan, Jianhua Hu, Maura Abbott, Gary K. Schwartz> ;Seminars in Oncology. 2021 Apr 1
• 5 citations
  Future of immunotherapy in pancreas cancer and the trials, tribulations and successes thus far.
  Winston Wong, Emily Linda Alouani, Alexander Wei, Yun Kyoung Ryu, John A. Chabot> ;Seminars in Oncology. 2021 Feb 1
• 32 citations
  A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
  Tamas A. Gonda, Jarwei Fang, Martha Salas, Catherine Do, Emily Hsu, Anna Zhukovskaya, Ariel Siegel, Ryota Takahashi, Zoila A. Lopez-Bujanda, Charles G. Drake, Gulam Ab...> ;Cancer Research. 2020 Nov 1
• 1 citations
  Sustained Partial Response to Inhibition of the Mitogen-Activated Protein Kinase and Autophagy Pathways in Combination With Immune Checkpoint Blockade in KRAS-Mutated ...
  Alexander G. Raufi, Winston Wong, Karen Chen, Alina Iuga, Firas S. Ahmed> ;JCO Precision Oncology. 2020 Sep 28
• Join now to see all

Lectures

• Phase 1 combination therapy with pexidartinib (PEX) and sirolimus (S) to target tumor-associated macrophages in pigmented villonodular synovitis, malignant peripheral ... 
  2019 ASCO Annual Meeting - 6/1/2019